
A new study that involved 40,000 people identified two new genetic variants which influence how 'bad' cholesterol levels respond to statin therapy. Statins are widely prescribed to patients and have been shown to lower bad cholesterol levels by up to 55%, making them a highly effective method of reducing risk of heart disease. However, despite this success, patient response can vary widely. The study, led by Queen Mary University of London and published ...
Read More
You have just read an article categorized health
titled Two New Genetic Variants Influencing Cholesterol Levels During Statin Therapy Identified.
Written by:
editor -
Wednesday, October 29, 2014
There are currently no comments for "Two New Genetic Variants Influencing Cholesterol Levels During Statin Therapy Identified"
Post a Comment